Rhenman & Partners将其在Privia Health的股权增加了近27.3%,而该公司的CFO出售股票。 Rhenman & Partners boosted its stake in Privia Health by nearly 27.3%, while the company’s CFO sold shares.

机构投资者Rhenman & Partners在Privia保健集团中的份额增加了27.3%,现在持有121 189股,价值约236万美元。 Institutional investor Rhenman & Partners increased its shares in Privia Health Group by 27.3%, now holding 121,189 shares worth about $2.36 million. Privia Health是一家帮助医生优化做法和加强病人护理的公司,其首席财务官David Mountcastle出售5 630股,价值125 999美元。 Privia Health, a company that aids physicians in optimizing practices and enhancing patient care, saw its CFO, David Mountcastle, sell 5,630 shares for $125,999. 该公司的股票于星期五开放21.97美元,市场上限为26.5亿美元。 The company's stock opened at $21.97 on Friday, with a market cap of $2.65 billion.